Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prulifloxacin versus levofloxacin for prevention of post-operative urinary bacterial infection after TURP
2006-005252-32Phase 2Terminated
- Sponsor
- Angelini Pharma
- Start
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of prulifloxacin and levofloxacin in urinary tract infection (UTI) (2 arms), sponsored by Angelini Pharma. Primary endpoint: Prophylactic effect in preventing urinary bacterial infections after TURP. Started Feb 2008; status: terminated.
02
Drugs
prulifloxacinlevofloxacin
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on 2006-005252-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005252-32.